Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

The Centers for Medicare & Medicaid Services (CMS) has released its proposed 2027 Hospital Outpatient Prospective Payment System rule, introducing a 2.4% outpatient payment increase while proposing significant reductions in the 340B Drug Pricing Program reimbursement and expanding site-neutral payment